Are you affected by the PPE shortage? Biederman-Farlow, LLC is a PPE wholesale supplier to many different industries. We have partnered with reliable manufacturers for quality listed products. View our product catalog and please inquire about our bulk order discounts. Trust us to be your supplier, and avoid overpriced, counterfeited products, or products that may never arrive.
You can order off our website, or call or email us for a bulk order quote, we always apply volume discounts.
In Stock Now!
You can order your Covid-19 At Home Test now!
Featured PPE Wholesale Supplier Products
- Biederman Farlow Teams With Omni InternationalBiederman Farlow LLC is proud to announce it has partnered with Omni International Corp to sell their high quality gloves, also their wound and first aid kits.
- PPE Masks and Their CounterfeitsHow Did We Get Here? In the beginning stages of the Covid-19 pandemic, it quickly became clear that the stock of Personal Protection Equipment, or PPE, […]
As of October 2021 the FDA has identified the following Device Shortage List. Biederman Farlow is dedicated on providing a trustworthy source of these products to the American people throughout the pandemic and beyond.
Categories of devices in the device shortage list are:
- Dialysis-Related Products
- Personal Protective Equipment
- Testing Supplies and Equipment
- Ventilation-Related Products
Under the Personal Protective Equipment category the shortage list includes:
- Latex, Nitrile, & Vinyl Gloves
- Gowns and Surgical Apparel
On March 27, 2020, the CARES Act was signed into law. Section 3121 of the CARES Act amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) by adding section 506J to the statute. Section 506J provides the FDA—for the first time—with authority intended to help prevent or mitigate medical device shortages “during, or in advance of, a public health emergency declared by the Secretary under section 319 of the PHS Act.” The provision includes requirements for manufacturers of certain devices to notify the FDA “of a permanent discontinuance in the manufacture of the device” or “an interruption in the manufacture of the device that is likely to lead to a meaningful disruption in supply of that device in the United States” during a declared public health emergency.
One provision of this new statutory authority—section 506J(g) of the FD&C Act—requires the FDA to maintain a publicly-available, up-to-date list of the devices the FDA has determined to be in shortage. In addition, the FDA is providing a list of medical devices for which the FDA has been notified that manufacturing has been permanently discontinued.